NUTRIBAND INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
NUTRIBAND INC. (NTRB) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $2.25 million as of 2018-10-31, per its 10-Q filed 2018-12-14.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2020-04-14
- 2018-10-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $2.25M.
- 2018-08-02: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $2.25M.
- 2018-08-01: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $2.25M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets |
|---|---|
| 2018-10-31 | $2.25M 10-Q · filed 2018-12-14 |
| 2018-08-02 | $2.25M 10-Q · filed 2019-12-12 |
| 2018-08-01 | $2.25M 10-K · filed 2020-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |